Endoscopy — Net Sales
Stryker Endoscopy — Net Sales decreased by 0.3% to $1.79B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.0%, from $1.67B to $1.79B. Over 3 years (FY 2021 to FY 2024), Endoscopy — Net Sales shows an upward trend with a 16.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates strong demand for minimally invasive surgical solutions and successful market penetration of new visualization technologies, while a decrease may signal competitive pressure or a slowdown in hospital capital equipment spending.
Detailed definition
This metric represents the total revenue generated from the sale of endoscopy systems, visualization equipment, and rela...
Peer comparison
Comparable to medical device segments focused on surgical visualization and minimally invasive instrumentation at peers like Medtronic, Olympus, or Intuitive Surgical.
syk_segment_endoscopy_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.04B | $1.05B | $1.26B | $1.08B | $1.20B | $1.18B | $1.39B | $1.40B | $1.41B | $1.48B | $1.78B | $1.56B | $1.54B | $1.67B | $2.01B | $1.73B | $1.80B | $1.79B |
| QoQ Change | — | +1.4% | +19.8% | -14.5% | +11.5% | -1.7% | +17.8% | +0.4% | +1.0% | +4.7% | +20.9% | -12.8% | -1.3% | +9.0% | +20.2% | -13.8% | +3.7% | -0.3% |
| YoY Change | — | — | — | — | +15.8% | +12.4% | +10.5% | +29.7% | +17.5% | +25.1% | +28.3% | +11.5% | +8.9% | +13.4% | +12.8% | +11.4% | +17.1% | +7.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's endoscopy — net sales?
- Stryker (SYK) reported endoscopy — net sales of $1.79B in Q3 2025.
- How has Stryker's endoscopy — net sales changed year-over-year?
- Stryker's endoscopy — net sales increased by 7.0% year-over-year, from $1.67B to $1.79B.
- What is the long-term trend for Stryker's endoscopy — net sales?
- Over 3 years (2021 to 2024), Stryker's endoscopy — net sales has grown at a 16.5% compound annual growth rate (CAGR), from $4.28B to $6.78B.
- What does endoscopy — net sales mean?
- The total revenue generated from the company's endoscopy and surgical visualization product line.